TGF-β in progression of liver disease

Cell and Tissue Research

Volumn 347, Issue 1, 2012, Pages 245-256

  Dooley, Steven ^a   Ten Dijke, Peter ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Epithelial to mesenchymal transition; Fibrosis; Hepatic stellate cell; Hepatocellular carcinoma; Inflammation; Liver disease; TGF

Indexed keywords

FRESOLIMUMAB; LERDELIMUMAB; MESSENGER RNA; METELIMUMAB; TRANSFORMING GROWTH FACTOR BETA;

ANTISENSE THERAPY; CELL ACTIVATION; CELL DAMAGE; CELL DEATH; CHRONIC LIVER DISEASE; DRUG MECHANISM; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX; EYE DISEASE; GENE; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER REGENERATION; LUNG FIBROSIS; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; REVIEW; RNA INTERFERENCE; SCAR FORMATION; STELLATE CELL; SYSTEMIC SCLEROSIS; TRANSFORMING GROWTH FACTOR BETA GENE; WOUND HEALING;

ANIMALS; CHRONIC DISEASE; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA;

EID: 84859445823     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-011-1246-y     Document Type: Review

References (109)

1. Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115:209-218 (Pubitemid 40385459)
2. Becker C, Fantini MC, Neurath MF (2006) TGF-β as a T cell regulator in colitis and colon cancer. Cytokine Growth Factor Rev 17:97-106 (Pubitemid 43117519)
3. Biname F, Lassus P, Hibner U (2008) Transforming growth factor β controls the directional migration of hepatocyte cohorts by modulating their adhesion to fibronectin.Mol Biol Cell 19:945-956 (Pubitemid 351481810)
4. Bohm F, Kohler UA, Speicher T, Werner S (2010) Regulation of liver regeneration by growth factors and cytokines. EMBO Mol Med 2:294-305
5. Braun L, Gruppuso P, Mikumo R, Fausto N (1990) Transforming growth factor β1 in liver carcinogenesis: messenger RNA expression and growth effects. Cell Growth Differ 1:103-111
6. Breitkopf K, Haas S, Wiercinska E, Singer MV, Dooley S (2005) Anti-TGF-β strategies for the treatment of chronic liver disease. Alcohol Clin Exp Res 29:121S-131S (Pubitemid 43194338)
7. Breitkopf K, Godoy P, Ciuclan L, Singer MV, Dooley S (2006) TGF-β/Smad signaling in the injured liver. Z Gastroenterol 44:57-66
8. Chu AS, Diaz R, Hui JJ, Yanger K, Zong Y, Alpini G, Stanger BZ, Wells RG (2011) Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis. Hepatology 53:1685-1695
9. Cui X, Shimizu I, Lu G, Itonaga M, Inoue H, Shono M, Tamaki K, Fukuno H, Ueno H, Ito S (2003) Inhibitory effect of a soluble transforming growth factor β type II receptor on the activation of rat hepatic stellate cells in primary culture. J Hepatol 39:731-737 (Pubitemid 37372181)
10. Denton CP, Abraham DJ (2004) Transgenic analysis of scleroderma: understanding key pathogenic events in vivo. Autoimmun Rev 3:285-293 (Pubitemid 38887624)
11. Dijke P ten, Arthur HM (2007) Extracellular control of TGFβ signalling in vascular development and disease. Nat Rev Mol Cell Biol 8:857-869 (Pubitemid 47622560)
12. Dooley S, Delvoux B, Lahme B, Mangasser-Stephan K, Gressner AM (2000) Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 31:1094-1106 (Pubitemid 30233234)
13. Dooley S, Delvoux B, Streckert M, Bonzel L, Stopa M, Ten DP, Gressner AM (2001a) Transforming growth factor beta signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFβ signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett 502:4-10 (Pubitemid 32722050)
14. Dooley S, Streckert M, Delvoux B, Gressner AM (2001b) Expression of Smads during in vitro transdifferentiation of hepatic stellate cells to myofibroblasts. Biochem Biophys Res Commun 283:554-562 (Pubitemid 32917925)
15. Dooley S, Hamzavi J, Breitkopf K, Wiercinska E, Said HM, Lorenzen J, Dijke ten P, Gressner AM (2003) Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125:178-191 (Pubitemid 36799118)
16. Dooley S, Hamzavi J, Ciuclan L, Godoy P, Ilkavets I, Ehnert S, Ueberham E, Gebhardt R, Kanzler S, Geier A, Breitkopf K, Weng H, Mertens PR (2008) Hepatocyte-specific Smad7 expression attenuates TGF-β-mediated fibrogenesis and protects against liver damage. Gastroenterology 135:642-659
17. Dooley S, Weng H, Mertens PR (2009) Hypotheses on the role of transforming growth factor-β in the onset and progression of hepatocellular carcinoma. Dig Dis 27:93-101
18. Duncan AW, Dorrell C, Grompe M (2009) Stem cells and liver regeneration. Gastroenterology 137:466-481
19. Ezquerro IJ, Lasarte JJ, Dotor J, Castilla-Cortazar I, Bustos M, Penuelas I, Blanco G, Rodriguez C, Lechuga MC, Greenwel P, Rojkind M, Prieto J, Borras-Cuesta F (2003) A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine 22:12-20 (Pubitemid 37222298)
20. Fausto N, Mead JE, Braun L, Thompson NL, Panzica M, Goyette M, Bell GI, Shank PR (1986) Proto-oncogene expression and growth factors during liver regeneration. Symp Fundam Cancer Res 39:69-86
21. Flanders KC, Sullivan CD, Fujii M, Sowers A, Anzano MA, Arabshahi A, Major C, Deng C, Russo A, Mitchell JB, Roberts AB (2002) Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. Am J Pathol 160:1057-1068 (Pubitemid 34224592)
22. Friedman SL (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247-2250
23. Friedman SL (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655-1669
24. Friedman SL (2010) Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 7:425-436
25. Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y, Nishizawa M, Fujisawa J, Inoue K (2003) p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 38:879-889 (Pubitemid 37221671)
26. George J, Roulot D, Koteliansky VE, Bissell DM (1999) In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci USA 96:12719-12724 (Pubitemid 29513569)
27. Giannelli G, Mazzocca A, Fransvea E, Lahn M, Antonaci S (2011) Inhibiting TGF-β signaling in hepatocellular carcinoma. Biochim Biophys Acta 1815:214-223
28. Godoy P, Hengstler JG, Ilkavets I, Meyer C, Bachmann A, Muller A, Tuschl G, Mueller SO, Dooley S (2009) Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β-induced apoptosis. Hepatology 49:2031-2043
29. Gotzmann J, Huber H, Thallinger C, Wolschek M, Jansen B, Schulte-Hermann R, Beug H, Mikulits W (2002) Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness. J Cell Sci 115:1189-1202 (Pubitemid 34272483)
30. Gressner OA, Gressner AM (2008) Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases. Liver Int 28:1065-1079
31. Hawinkels LJ, Dijke P ten (2011) Exploring anti TGF-β therapies in cancer and fibrosis. Growth Factors 29:140-152
32. Hayashi I, Carr BI (1985) DNA synthesis in rat hepatocytes: inhibition by a platelet factor and stimulation by an endogenous factor. J Cell Physiol 125:82-90 (Pubitemid 15012072)
33. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA (1999) The role of TGFβ1 in initiating hepatic stellate cell activation in vivo. J Hepatol 30:77-87 (Pubitemid 29023655)
34. Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, Neuhaus P, Gressner AM, Schuppan D (1997) Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol 150:1647-1659 (Pubitemid 27193813)
35. Heymann F, Trautwein C, Tacke F (2009) Monocytes and macrophages as cellular targets in liver fibrosis. Inflamm Allergy Drug Targets 8:307-318
36. Hoshida Y, Toffanin S, Lachenmayer A, Villanueva A, Minguez B, Llovet JM (2010) Molecular classification and novel targets in hepatocellular carcinoma: recent advancements. Semin Liver Dis 30:35-51
37. Houck KA, Michalopoulos GK, Strom SC (1989) Introduction of a Ha-ras oncogene into rat liver epithelial cells and parenchymal hepatocytes confers resistance to the growth inhibitory effects of TGF-β. Oncogene 4:19-25 (Pubitemid 19085064)
38. Im YH, Kim HT, Kim IY, Factor VM, Hahm KB, Anzano M, Jang JJ, Flanders K, Haines DC, Thorgeirsson SS, Sizeland A, Kim SJ (2001) Heterozygous mice for the transforming growth factor-β type II receptor gene have increased susceptibility to hepatocellular carcinogenesis. Cancer Res 61:6665-6668 (Pubitemid 32896482)
39. Inagaki Y, Truter S, Greenwel P, Rojkind M, Unoura M, Kobayashi K, Ramirez F (1995) Regulation of the α2(I) collagen gene transcription in fat-storing cells derived from a cirrhotic liver. Hepatology 22:573-579
40. Inagaki Y, Mamura M, Kanamaru Y, Greenwel P, Nemoto T, Takehara K, ten Dijke P, Nakao A (2001a) Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J Cell Physiol 187:117-123 (Pubitemid 32195252)
41. Inagaki Y, Nemoto T, Nakao A, Dijke P ten, Kobayashi K, Takehara K, Greenwel P (2001b) Interaction between GC box binding factors and Smad proteins modulates cell lineage-specific α2(I) collagen gene transcription. J Biol Chem 276:16573-16579
42. Iredale JP (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Investig 117:539-548
43. Iyer S, Wang ZG, Akhtari M, Zhao W, Seth P (2005) Targeting TGFβ signaling for cancer therapy. Cancer Biol Ther 4:261-266 (Pubitemid 41357481)
44. Jang CW, Chen CH, Chen CC, Chen JY, Su YH, Chen RH (2002) TGF-β induces apoptosis through Smad-mediated expression of DAP-kinase. Nat Cell Biol 4:51-58 (Pubitemid 34071980)
45. Jinnin M, Ihn H, Tamaki K (2006) Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression. Mol Pharmacol 69:597-607 (Pubitemid 43121957)
46. Kaimori A, Potter J, Kaimori JY, Wang C, Mezey E, Koteish A (2007) Transforming growth factor-β1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro. J Biol Chem 282:22089-22101 (Pubitemid 47195788)
47. Kanzler S, Lohse AW, Keil A, Henninger J, Dienes HP, Schirmacher P, Rose-John S, Buschenfelde KH zum, Blessing M (1999) TGF-β1 in liver fibrosis: an inducible transgenic mouse model to study liver fibrogenesis. Am J Physiol 276:G1059-G1068 (Pubitemid 29214121)
48. Kanzler S, Meyer E, Lohse AW, Schirmacher P, Henninger J, Galle PR, Blessing M (2001) Hepatocellular expression of a dominant-negative mutant TGF-β type II receptor accelerates chemically induced hepatocarcinogenesis. Oncogene 20:5015-5024 (Pubitemid 32769791)
49. Knittel T, Fellmer P, Ramadori G (1996) Gene expression and regulation of plasminogen activator inhibitor type I in hepatic stellate cells of rat liver. Gastroenterology 111:745-754 (Pubitemid 26293241)
50. Korn T, Bettelli E, Oukka M, Kuchroo VK (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27:485-517
51. Latella G, Vetuschi A, Sferra R, Catitti V, D'Angelo A, Zanninelli G, Flanders KC, Gaudio E (2009) Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine-induced hepatic fibrosis in mice. Liver Int 29:997-1009
52. Lee JS, Thorgeirsson SS (2006) Comparative and integrative functional genomics of HCC. Oncogene 25:3801-3809
53. Liu C, Gaca MD, Swenson ES, Vellucci VF, Reiss M, Wells RG (2003) Smads 2 and 3 are differentially activated by transforming growth factor-β (TGF-β) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J Biol Chem 278:11721-11728 (Pubitemid 36792736)
54. Liu X, Wang W, Hu H, Tang N, Zhang C, Liang W, Wang M (2006) Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-β1 in cultured rat hepatic stellate cells. Pharm Res 23:82-89 (Pubitemid 43214663)
55. Matsuzaki K (2009) Modulation of TGF-β signaling during progression of chronic liver diseases. Front Biosci 14:2923-2934
56. Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, Kaibori M, Kamiyama Y, Nishizawa M, Fujisawa J, Okazaki K, Seki T (2007) Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology 46:48-57 (Pubitemid 47171920)
57. Mead AL, Wong TT, Cordeiro MF, Anderson IK, Khaw PT (2003) Evaluation of anti-TGF-β2 antibody as a new postoperative antiscarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci 44:3394-3401 (Pubitemid 36909776)
58. Meyer C, Meindl-Beinker NM, Dooley S (2010) TGF-β signaling in alcohol induced hepatic injury. Front Biosci 15:740-749
59. Michalopoulos GK (2007) Liver regeneration. J Cell Physiol 213:286-300
60. Michalopoulos GK (2011) Liver regeneration: alternative epithelial pathways. Int J Biochem Cell Biol 43:173-179
61. Mishra L, Banker T, Murray J, Byers S, Thenappan A, He AR, Shetty K, Johnson L, Reddy EP (2009) Liver stem cells and hepatocellular carcinoma. Hepatology 49:318-329
62. Moustakas A, Kardassis D (1998) Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci USA 95:6733-6738 (Pubitemid 28278049)
63. Murillo MM, del Castillo G, Sanchez A, Fernandez M, Fabregat I (2005) Involvement of EGF receptor and c-Src in the survival signals induced by TGF-β1 in hepatocytes. Oncogene 24:4580-4587 (Pubitemid 41032621)
64. Nakamura T, Tomita Y, Hirai R, Yamaoka K, Kaji K, Ichihara A (1985) Inhibitory effect of transforming growth factor-β on DNA synthesis of adult rat hepatocytes in primary culture. Biochem Biophys Res Commun 133:1042-1050 (Pubitemid 16142884)
65. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H (2000) Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 32:247-255 (Pubitemid 30614657)
66. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I (1999) Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 104:5-11 (Pubitemid 29534339)
67. Nakatsukasa H, Nagy P, Evarts RP, Hsia CC, Marsden E, Thorgeirsson SS (1990) Cellular distribution of transforming growth factor-β1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis. J Clin Invest 85:1833-1843 (Pubitemid 20192957)
68. Nieto N, Dominguez-Rosales JA, Fontana L, Salazar A, Armendariz-Borunda J, Greenwel P, Rojkind M (2001) Rat hepatic stellate cells contribute to the acute-phase response with increased expression of α1(I) and α1(IV) collagens, tissue inhibitor of metalloproteinase-1, and matrix- metalloproteinase-2 messenger RNAs. Hepatology 33:597-607 (Pubitemid 32185222)
69. Oberhammer F, Bursch W, Parzefall W, Breit P, Erber E, Stadler M, Schulte-Hermann R (1991) Effect of transforming growth factor β on cell death of cultured rat hepatocytes. Cancer Res 51:2478-2485
70. Omenetti A, Choi S, Michelotti G, Diehl AM (2011) Hedgehog signaling in the liver. J Hepatol 54:366-373
71. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
72. Pennison M, Pasche B (2007) Targeting transforming growth factor-β signaling. Curr Opin Oncol 19:579-585 (Pubitemid 47508864)
73. Perlman R, Schiemann WP, Brooks MW, Lodish HF, Weinberg RA (2001) TGF-β-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. Nat Cell Biol 3:708-714 (Pubitemid 32734248)
74. Petersen M, Thorikay M, Deckers M, Dinther M van, Grygielko ET, Gellibert F, Gouville AC de, Huet S, Dijke P ten, Laping NJ (2008) Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis. Kidney Int 73:705-715 (Pubitemid 351323246)
75. Popov Y, Schuppan D (2010) Epithelial-to-mesenchymal transition in liver fibrosis: dead or alive? Gastroenterology 139:722-725
76. Qi Z, Atsuchi N, Ooshima A, Takeshita A, Ueno H (1999) Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci USA 96:2345-2349 (Pubitemid 29117917)
77. Ramesh S, Qi XJ, Wildey GM, Robinson J, Molkentin J, Letterio J, Howe PH (2008) TGFβ-mediated BIM expression and apoptosis are regulated through SMAD3-dependent expression of the MAPK phosphatase MKP2. EMBO Rep 9:990-997
78. Reimann T, Hempel U, Krautwald S, Axmann A, Scheibe R, Seidel D, Wenzel KW (1997) Transforming growth factor-β1 induces activation of Ras, Raf-1, MEK and MAPK in rat hepatic stellate cells. FEBS Lett 403:57-60 (Pubitemid 27079809)
79. Rombouts K, Marra F (2010) Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. Dig Dis 28:229-235
80. Roskams T, Kojiro M (2010) Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis. Semin Liver Dis 30:17-25
81. Roth S, Michel K, Gressner AM (1998) (Latent) transforming growth factor β in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells. Hepatology 27:1003-1012 (Pubitemid 28160486)
82. Rowe RG, Lin Y, Shimizu-Hirota R, Hanada S, Neilson EG, Greenson JK, Weiss SJ (2011) Hepatocyte-derived snail1 propagates liver fibrosis progression. Mol Cell Biol 31:2392-2403
83. Schlingensiepen KH, Fischer-Blass B, Schmaus S, Ludwig S (2008) Antisense therapeutics for tumor treatment: the TGF-β2 inhibitor AP 12009 in clinical development against malignant tumors. Recent Results Cancer Res 177:137-150
84. Schnabl B, Kweon YO, Frederick JP, Wang XF, Rippe RA, Brenner DA (2001) The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34:89-100 (Pubitemid 32591487)
85. Schwall RH, Robbins K, Jardieu P, Chang L, Lai C, Terrell TG (1993) Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 18:347-356 (Pubitemid 23225106)
86. Seyhan H, Hamzavi J, Wiercinska E, Gressner AM, Mertens PR, Kopp J, Horch RE, Breitkopf K, Dooley S (2006) Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J Cell Mol Med 10:922-932
87. Stopa M, Anhuf D, Terstegen L, Gatsios P, Gressner AM, Dooley S (2000a) Participation of Smad2, Smad3, and Smad4 in transforming growth factor β (TGF-β)-induced activation of Smad7. The TGF-β response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J Biol Chem 275:29308-29317 (Pubitemid 32043801)
88. Stopa M, Benes V, Ansorge W, Gressner AM, Dooley S (2000b) Genomic locus and promoter region of rat Smad7, an important antagonist of TGFβ signaling. Mamm Genome 11:169-176 (Pubitemid 30054422)
89. Strain AJ, Frazer A, Hill DJ, Milner RD (1987) Transforming growth factor β inhibits DNA synthesis in hepatocytes isolated from normal and regenerating rat liver. Biochem Biophys Res Commun 145:436-442 (Pubitemid 17088456)
90. Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K (2002) Differential regulation of TGF-β signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35:49-61 (Pubitemid 34032543)
91. Tallima H, Salah M, Guirguis FR, El Ridi R (2009) Transforming growth factor-β and Th17 responses in resistance to primary murine schistosomiasis mansoni. Cytokine 48:239-245
92. Taura K, Miura K, Iwaisako K, Osterreicher CH, Kodama Y, Penz-Osterreicher M, Brenner DA (2010) Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51:1027-1036
93. Ueberham E, Low R, Ueberham U, Schonig K, Bujard H, Gebhardt R (2003) Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37:1067-1078 (Pubitemid 36538683)
94. Uemura M, Swenson ES, Gaca MD, Giordano FJ, Reiss M, Wells RG (2005) Smad2 and Smad3 play different roles in rat hepatic stellate cell function and α-smooth muscle actin organization. Mol Biol Cell 16:4214-4224 (Pubitemid 41262890)
95. Ueno H, Sakamoto T, Nakamura T, Qi Z, Astuchi N, Takeshita A, Shimizu K, Ohashi H (2000) A soluble transforming growth factor β receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum Gene Ther 11:33-42 (Pubitemid 30044038)
96. Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, Wagner RA, Greaves DR, Murray PJ, Chawla A (2006) Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab 4:13-24 (Pubitemid 43942258)
97. Venook AP, Papandreou C, Furuse J, Guevara LL de (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15(Suppl 4):5-13
98. Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, Brenner M, Guo G, Zhang W, Oliver N, Lin A, Yeowell D (2011) Cooperative interaction of CTGF and TGF-β in animal models of fibrotic disease. Fibrogenesis Tissue Repair 4:4
99. Weber A, Boege Y, Reisinger F, Heikenwalder M (2011) Chronic liver inflammation and hepatocellular carcinoma: persistence matters. Swiss Med Wkly 141:w13197
100. Weng HL, Ciuclan L, Liu Y, Hamzavi J, Godoy P, Gaitantzi H, Kanzler S, Heuchel R, Ueberham U, Gebhardt R, Breitkopf K, Dooley S (2007) Profibrogenic transforming growth factor-β/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes. Hepatology 46:1257-1270 (Pubitemid 350144790)
101. Whittaker S, Marais R, Zhu AX (2010) The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29:4989-5005
102. Wiercinska E, Wickert L, Denecke B, Said HM, Hamzavi J, Gressner AM, Thorikay M, Dijke P ten, Mertens PR, Breitkopf K, Dooley S (2006) Id1 is a critical mediator in TGF-β-induced transdifferentiation of rat hepatic stellate cells. Hepatology 43:1032-1041 (Pubitemid 43738969)
103. Wynn TA (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4:583-594
104. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, Asano S, Kojima I (1993) Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 92:1491-1496 (Pubitemid 23273929)
105. Yata Y, Gotwals P, Koteliansky V, Rockey DC (2002) Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-β soluble receptor: implications for antifibrotic therapy. Hepatology 35:1022-1030 (Pubitemid 34453999)
106. Yingling JM, Blanchard KL, Sawyer JS (2004) Development of TGF-beta signalling inhibitors for cancer therapy. Nat Rev Drug Discov 3:1011-1022 (Pubitemid 39642364)
107. Yoshida K, Matsuzaki K, Mori S, Tahashi Y, Yamagata H, Furukawa F, Seki T, Nishizawa M, Fujisawa J, Okazaki K (2005) Transforming growth factor-β and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am J Pathol 166:1029-1039 (Pubitemid 40524428)
108. Zeisberg M, Yang C, Martino M, Duncan MB, Rieder F, Tanjore H, Kalluri R (2007) Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J Biol Chem 282:23337-23347 (Pubitemid 47311952)
109. Zhang B, Halder SK, Zhang S, Datta PK (2009) Targeting transforming growth factor-β signaling in liver metastasis of colon cancer. Cancer Lett 277:114-120